Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMUV8OR)

Drug Name

Indecainide Drug Info

Synonyms

Indecainida; Indecainidum; Ricainid; Ricainide; Indecainida [Spanish]; Indecainide [INN]; Indecainidum [Latin]; Decabid (TN); LY-135837; 9-(3-((1-methylethyl)amino)propyl)-9H-fluorene-9-carboxamide; 9-(3-(Isopropylamino)propyl))fluorene-9-carboxamide; 9-(3-(Isopropylamino)propyl)-9-fluorenylcarboxamid; 9-[3-(propan-2-ylamino)propyl]fluorene-9-carboxamide

Indication

Disease Entry	ICD 11	Status	REF
Dysrhythmias	BC9Z	Approved	[1]

Therapeutic Class

Antidysrhythmic Agents

Cross-matching ID

PubChem CID: 52195
ChEBI ID: CHEBI:135314
CAS Number: CAS 74517-78-5
TTD Drug ID: DMUV8OR

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Voltage-gated sodium channel alpha Nav1.5 (SCN5A)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Mephenytoin	DM5UGDK	Epilepsy	8A60-8A68	Approved	[3]
Mexiletine	DMCTE9R	Ventricular tachycardia	BC71	Approved	[4]
Fosphenytoin	DMOX3LB	Epilepsy	8A60-8A68	Approved	[3]
Disopyramide	DM5SYZP	Long QT syndrome	BC65.0	Approved	[4]
LOMERIZINE	DME0TC8	Migraine	8A80	Approved	[5]
Tetrodotoxin	DMWMPRG	Bacterial infection	1A00-1C4Z	Approved	[6]
Dyclonine	DMU6OFP	Pain	MG30-MG3Z	Approved	[7]
Moricizine	DMOMBJW	Arrhythmia	BC9Z	Approved	[8]
Ethotoin	DMXWOCP	Complex partial seizure	8A68.0	Approved	[9]
Prilocaine	DMI7DZ2	Pain	MG30-MG3Z	Approved	[7]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Voltage-gated sodium channel alpha Nav1.5 (SCN5A)	TTZOVE0	SCN5A_HUMAN	Blocker	[2]

------------------------------------------------------------------------------------

References

1	FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 019693.
2	Electrophysiological studies of indecainide hydrochloride, a new antiarrhythmic agent, in canine cardiac tissues. J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):614-21.
3	Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders. CNS Drugs. 2009;23(7):555-68.
4	Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol. 2000 Dec;11(12):1320-9.
5	Medicinal chemistry of neuronal voltage-gated sodium channel blockers. J Med Chem. 2001 Jan 18;44(2):115-37.
6	Halothane attenuates the cerebroprotective action of several Na+ and Ca2+ channel blockers via reversal of their ion channel blockade. Eur J Pharmacol. 2002 Oct 4;452(2):175-81.
7	Monoamine transporter and sodium channel mechanisms in the rapid pressor response to cocaine. Pharmacol Biochem Behav. 1998 Feb;59(2):305-12.
8	From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials. Am J Cardiol. 1996 Aug 29;78(4A):28-33.
9	How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.